Diagnostic Utility of Endocan and Interleukins for Late-Onset Neonatal Sepsis

The aim of this study was to determine the potential of early inflammatory markers to diagnose late-onset neonatal sepsis – interleukin 6 (IL-6), interleukin 8 (IL-8) and endocan (ESM-1), and to compare them with routinely used markers like C-reactive protein (CRP) and procalcitonin (PCT). A prospec...

Full description

Saved in:
Bibliographic Details
Main Authors: Preslava Gatseva, Alexander Blazhev, Zarko Yordanov, Victoria Atanasova
Format: Article
Language:English
Published: Medical University - Pleven 2023-12-01
Series:Journal of Biomedical & Clinical Research
Subjects:
Online Access:https://jbcr.arphahub.com/article/34682/download/pdf/
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839616958370152448
author Preslava Gatseva
Alexander Blazhev
Zarko Yordanov
Victoria Atanasova
author_facet Preslava Gatseva
Alexander Blazhev
Zarko Yordanov
Victoria Atanasova
author_sort Preslava Gatseva
collection DOAJ
description The aim of this study was to determine the potential of early inflammatory markers to diagnose late-onset neonatal sepsis – interleukin 6 (IL-6), interleukin 8 (IL-8) and endocan (ESM-1), and to compare them with routinely used markers like C-reactive protein (CRP) and procalcitonin (PCT). A prospective (January, 2022 – January, 2023) clinical-epidemiological study was conducted in a third level NICU in Pleven, Bulgaria. Patients with suspected nosocomial infection and healthy controls were tested. A sandwich ELISA method was used to measure the serum concentrations. Sixty newborns with an average gestational age of 29.75±3.61 gestational weeks were included, of which 35% were symptomatic and infected, 33.3% were symptomatic but uninfected, and 31.7% were asymptomatic controls. The mean values of PCT and IL-6 differ significantly in the three groups. For ESM-1, IL-8 and CRP, the difference was statistically insignificant. The best sensitivity (78%) and negative predictive value (84%) was found for IL-6. The introduction into routine practice of indicators such as PCT and IL-6 may provide an opportunity to promptly optimize the diagnostic and therapeutic approach to LOS.
format Article
id doaj-art-f1dfac5edb9b48e2ab2a7c24e1cf57f4
institution Matheson Library
issn 1313-9053
language English
publishDate 2023-12-01
publisher Medical University - Pleven
record_format Article
series Journal of Biomedical & Clinical Research
spelling doaj-art-f1dfac5edb9b48e2ab2a7c24e1cf57f42025-07-25T07:34:06ZengMedical University - PlevenJournal of Biomedical & Clinical Research1313-90532023-12-0116212413010.2478/jbcr-2023-001634682Diagnostic Utility of Endocan and Interleukins for Late-Onset Neonatal SepsisPreslava GatsevaAlexander BlazhevZarko YordanovVictoria AtanasovaThe aim of this study was to determine the potential of early inflammatory markers to diagnose late-onset neonatal sepsis – interleukin 6 (IL-6), interleukin 8 (IL-8) and endocan (ESM-1), and to compare them with routinely used markers like C-reactive protein (CRP) and procalcitonin (PCT). A prospective (January, 2022 – January, 2023) clinical-epidemiological study was conducted in a third level NICU in Pleven, Bulgaria. Patients with suspected nosocomial infection and healthy controls were tested. A sandwich ELISA method was used to measure the serum concentrations. Sixty newborns with an average gestational age of 29.75±3.61 gestational weeks were included, of which 35% were symptomatic and infected, 33.3% were symptomatic but uninfected, and 31.7% were asymptomatic controls. The mean values of PCT and IL-6 differ significantly in the three groups. For ESM-1, IL-8 and CRP, the difference was statistically insignificant. The best sensitivity (78%) and negative predictive value (84%) was found for IL-6. The introduction into routine practice of indicators such as PCT and IL-6 may provide an opportunity to promptly optimize the diagnostic and therapeutic approach to LOS.https://jbcr.arphahub.com/article/34682/download/pdf/neonateslate-onset sepsisinflammatory markers
spellingShingle Preslava Gatseva
Alexander Blazhev
Zarko Yordanov
Victoria Atanasova
Diagnostic Utility of Endocan and Interleukins for Late-Onset Neonatal Sepsis
Journal of Biomedical & Clinical Research
neonates
late-onset sepsis
inflammatory markers
title Diagnostic Utility of Endocan and Interleukins for Late-Onset Neonatal Sepsis
title_full Diagnostic Utility of Endocan and Interleukins for Late-Onset Neonatal Sepsis
title_fullStr Diagnostic Utility of Endocan and Interleukins for Late-Onset Neonatal Sepsis
title_full_unstemmed Diagnostic Utility of Endocan and Interleukins for Late-Onset Neonatal Sepsis
title_short Diagnostic Utility of Endocan and Interleukins for Late-Onset Neonatal Sepsis
title_sort diagnostic utility of endocan and interleukins for late onset neonatal sepsis
topic neonates
late-onset sepsis
inflammatory markers
url https://jbcr.arphahub.com/article/34682/download/pdf/
work_keys_str_mv AT preslavagatseva diagnosticutilityofendocanandinterleukinsforlateonsetneonatalsepsis
AT alexanderblazhev diagnosticutilityofendocanandinterleukinsforlateonsetneonatalsepsis
AT zarkoyordanov diagnosticutilityofendocanandinterleukinsforlateonsetneonatalsepsis
AT victoriaatanasova diagnosticutilityofendocanandinterleukinsforlateonsetneonatalsepsis